Pittenger, Mark F. http://orcid.org/0000-0003-2744-1765
Discher, Dennis E.
PĂ©ault, Bruno M.
Phinney, Donald G. http://orcid.org/0000-0002-8688-2619
Hare, Joshua M.
Caplan, Arnold I.
Article History
Received: 30 January 2019
Accepted: 20 September 2019
First Online: 2 December 2019
Competing interests
: M.F.P. is a founder of Longevity Therapeutics, Inc. J.M.H. reported having a patent for cardiac cell-based therapy. He holds equity in Vestion Inc. and maintains a professional relationship with Vestion Inc. as a consultant and member of the Board of Directors and Scientific Advisory Board. J.M.H. is the Chief Scientific Officer, a compensated consultant and advisory board member for Longeveron and holds equity in Longeveron. He is also the co-inventor of intellectual property licensed to Longeveron. BMP is co-inventor of intellectual property on native MSCs for therapeutic use, held by the University of California, Los Angeles. The other authors declare no competing interests.